Amarin Corp Plc (AMRN)

[circuitcity]

JL some comments:

1) we just established with rose’s dd that world #1 and #2 drugs’ rev in row (including japan and Eu big 5) is only 20% or less of us rev. So even if amrn is willing to supplement us with Eu profit, not saying this is business savvy yet, generic probably has deeper pockets yo do the same.
2) guess you are not suggesting doing this forever, guess you mean to jack up price once generics stop v offering, you said v manufacturing is tricky, but the reality said otherwise that Hikma got their ANDA approved pretty fast. That tells me that they can come back pretty fast when amrn increase price.